Tips and tricks for your Eupry platform + new features
Are you getting everything out of your Eupry platform? Or just curious to see what it can do? In this session, we lift the lid on the settings, features, and updates that save you time and take the friction out of your day-to-day work.
October 1, 2026
There is more in your Eupry platform than you might know…
Many teams use a fraction of what their platform can do – and new features and functionality are constantly being added.
But which settings are worth a second look?
What features have the biggest payoff for your daily operations?
And what are the most important recent updates to the platform?
Join us for this session, where Eupry's VP of Product, Martin Koo Rosenmejer, and CEO, Christian Jacobsen, walk through the best practices for using Eupry's monitoring and mapping software, the newest features, and what is coming next.
Key takeaways
- Best practices (and a few hacks) for using the platform
- Examples of how other teams have structured their workflows
- The latest improvements and new features
- A sneak peek into the roadmap of what is coming next
Sign up now
Join us for a session on the best practices for using Eupry's monitoring and mapping software, the newest features, and what is coming next.
Date: October 1, 2026
Time: 10:30 a.m. EDT | 3:30 p.m. BST | 4:30 p.m. CEST_
The speakers
- Martin Koo Rosenmejer, VP of Product at Eupry: Martin has almost 15 years of experience developing tech products in regulated and complex industries. Today, he leads product development at Eupry and is responsible for developing technology that simplifies compliance operations while meeting the standards pharmaceutical operations require.
- Christian Jacobsen, CEO: Christian co-founded Eupry in 2014 to solve two problems at once: medicine that loses efficacy and the bright people stuck doing manual compliance work to prevent it. As CEO, he leads the company’s mission to remove complexity from GxP compliance across the pharmaceutical supply chain — so every cure reaches the patient, and the teams behind it can focus on the work that matters.
